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Abstract 49 
Thalidomide notoriously caused severe birth defects, particularly to the limbs, in 50 
those exposed in utero following maternal use of the drug to treat morning sickness. 51 
How the drug caused these birth defects remains unclear. Many theories have been 52 
proposed including actions on the forming blood vessels. However, thalidomide 53 
survivors also have altered nerve patterns and the drug is known for its neurotoxic 54 
actions in adults following prolonged use. We have previously shown that CPS49, an 55 
antiangiogenic analog of thalidomide, causes a range of limb malformations in a time 56 
sensitive manner in chicken embryos. Here we investigated if CPS49 also is 57 
neurotoxic and if effects on nerve development impact upon limb development. We 58 
found that CPS49 is neurotoxic, just like thalidomide, and can cause some neuronal 59 
loss but only in late developing chicken limbs when the limb is already innervated. 60 
However, CPS49 exposure does not cause defects in limb size when added to late 61 
developing chicken limbs. In contrast, in early limb buds which are not innervated, 62 
CPS49 exposure affects limb area significantly. To investigate in more detail the role 63 
of neurotoxicity and its impact on chicken limb development we inhibited nerve 64 
innervation at a range of developmental timepoints through using β-bungarotoxin.  65 
We found that neuronal inhibition or ablation before, during or after limb outgrowth 66 
and innervation does not result in obvious limb cartilage patterning or number 67 
changes. We conclude that while CPS49 is neurotoxic, given the late innervation of 68 
the developing limb, and that neuronal inhibition/ablation throughout limb 69 
development does not cause similar limb patterning anomalies to those seen in 70 
thalidomide survivors, nerve defects are not the primary underlying cause of the 71 
severe limb patterning defects induced by CPS49/thalidomide. 72 
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Introduction 75 
In the late 1950s and early 1960s, thalidomide, a non-addictive, non-barbiturate 76 
sedative, was prescribed to pregnant mothers to treat morning sickness (Vargesson, 77 
2013; Vargesson, 2015). Embryonic exposure to thalidomide in a short time-78 
sensitive window resulted in over 10000 children worldwide being born with a range 79 
of birth defects including severe and debilitating limb defects, the most common 80 
being phocomelia (loss of proximal elements) (Smithells and Newman, 1992; 81 
Vargesson, 2009). Thalidomide also is a potent antiangiogenic and anti-inflammatory 82 
drug, that more recently has been shown to be effective in the treatment of multiple 83 
myeloma, ENL (a side-effect of leprosy) and a wide range of other conditions 84 
including Behcets disease, Crohns disease, HIV and graft-versus-host disorders 85 
(Vargesson, 2015). However, the drug carries severe side effects, such as 86 
teratogenesis, following embryonic exposure, and peripheral neuropathy following 87 
long term use in adults. Further understanding of the molecular and morphological 88 
action of this drug will aid in uncovering newer, safer alternatives. This has begun to 89 
be addressed recently through studying the pharmacological properties of analogs or 90 
breakdown products of the drug experimentally and clinically (Beedie et al., 2015; 91 
Beedie et al., 2016; Mahony et al., 2013; Richardson et al., 2010). Our previous 92 
studies of an antiangiogenic thalidomide analog, CPS49, demonstrated the drug 93 
leads to widespread loss of blood vessels throughout the limb, when applied at the 94 
time of rapid limb growth (Hamburger and Hamilton (HH) St17-19 in the chicken 95 
embryo), and disrupts the actin cytoskeleton of endothelial cells in-vitro (Therapontos 96 
et al., 2009). These vessel defects precede increased cell death, changes in 97 
expression patterns of signalling pathways vital for normal limb development and 98 
loss of proximal/medial tissue and structures (Therapontos et al., 2009; Vargesson, 99 
2009). These findings point towards the antiangiogenic properties of thalidomide 100 
being responsible for the drug’s teratogenic activity. Aside from missing 101 
proximal/medial limb skeletal elements, thalidomide survivors also have disrupted 102 
neurological patterns (McCredie et al., 1984). Consequently, it has been proposed 103 
that neurological damage caused by the drug could contribute to thalidomide’s 104 
damaging effects upon the embryo, including the developing limb (McCredie and 105 
McBride, 1973). In agreement with this idea, we have demonstrated that thalidomide 106 
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has a direct neurotoxic action on developing neurites (Mahony et al., 2013). 107 
However, developing chicken limbs form with normal cartilage patterns following loss 108 
of nerves before or during limb outgrowth occurs (Edom-Vovard et al., 2002; Harsum 109 
et al., 2001; Martin and Lewis, 1989; Strecker and Stephens, 1983; Swanson, 1985; 110 
Swanson and Lewis, 1982;). Moreover, disrupted nerve patterning in developing 111 
mouse limbs following loss of nerve guidance cues has no obvious impact on limb 112 
patterning, but does alter bone density and length (Fukuda et al., 2013; Tomlinson et 113 
al., 2016). Thus, the role of neurotoxicity in thalidomide-induced limb embryopathy is 114 
currently unclear. 115 
To further investigate the role of neurotoxicity in inducing limb defects we have 116 
analysed the effect of CPS49 on chicken limb innervation and development at a 117 
range of developmental timepoints; before, during and after limb initiation and 118 
outgrowth. We have further investigated the role nerves play in mediating correct 119 
limb development by applying β-bungarotoxin, a potent neurotoxin from snakes that 120 
prevents the neurotransmission of signals along the nerves permanently, to ablate 121 
nerves from the developing limb at different developmental timepoints. Our findings 122 
demonstrate that CPS49 is neurotoxic in-vitro, but induces only minor changes in 123 
nerve-patterning in CPS49 treated chicken embryo limbs. Moreover, through using 124 
β-bungarotoxin at different developmental timepoints we found that, unlike CPS49 125 
treatment, loss of nerves prior to, during or after limb initiation, does not result in the 126 
range of limb defects associated with CPS49 administration to chicken embryos. 127 
These findings demonstrate that (i) the neurotoxic actions of CPS49 are not 128 
responsible for the severe limb patterning malformations the drug causes; (ii) nerve 129 
inhibition/ablation before, during and after limb outgrowth in the chicken embryo 130 
does not result in loss of limb elements. 131 
Materials and Methods 132 
Chicken Embryos 133 
Fertilised White Leghorn chicken embryos (Henry Stewart, Herefordshire, UK) were 134 
incubated at 37°C. Embryos were staged according to Hamburger and Hamilton 135 
(HH) (Hamburger and Hamilton, 1992).  Compounds were dissolved in DMSO 136 
(Sigma Aldrich) and diluted in prewarmed DMEM (Sigma Aldrich) to give a final 137 
DMSO concentration of 0.1%. 100µl of the drug solution was applied to the upper 138 
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half of the embryos, as described previously (Therapontos et al., 2009).  Right 139 
(treated) forelimbs from treated embryos were compared to either contralateral limbs 140 
or right forelimbs from stage matched DMSO control embryos or right forelimbs from 141 
stage matched untreated controls. 142 
 143 
Cartilage staining 144 
Embryos where incubated until day 7/8 and fixed in 5% trichloroacetic acid overnight, 145 
rinsed in 70% alcohol for 5 min then washed twice in acid alcohol (1% concentrated 146 
Hydrochloric acid in 70% alcohol) for 10min. Embryos were stained with Alcian blue 147 
(0.1% in acid alcohol) for 6hr, rinsed in acid alcohol overnight, dehydrated in ethanol, 148 
cleared in methyl salicylate (Sigma Aldrich), and photographed. 149 
 150 
Immunohistochemistry  151 
Wholemount Immunohistochemistry was based on previously published protocols 152 
(Vargesson and Laufer, 2001). Briefly, embryos were dissected, then incubated in 153 
dents fix overnight, followed by dents bleach overnight. Embryos were washed 3 x 154 
1hr in 100 % methanol, followed by 3x 1hr PBS washes. Embryos were incubated in 155 
1° antibody (3A10, 1:20; Developmental Studies Hybridoma Bank) overnight, in a 156 
solution of 5% goat serum and 20% DMSO in PBS. The next day, the tissue was 157 
washed in 5x 1hr PBS, followed by incubation with 2° antibody (goat antirabbit-Cy3, 158 
1:1000; Jackson Immunoresearch) in 5% donkey serum and 20% DMSO in PBS. 159 
The next day tissue was washed in PBS 5x 1hr, followed by 3x 100% methanol 160 
washes. The tissue was cleared in Benzyl Alcohol/Benzyl Benzoate, and imaged. 161 
 162 
Retinal growth cone explant cultures  163 
Experiments were performed using E14.5 C57BL/6J embryos from an inhouse 164 
breeding colony. Noon on the day a vaginal plug as found was considered E0.5. 165 
Retinal explants were prepared as described previously (Erskine et al., 2011) and 166 
cultured in a 1:1 mixture of bovine dermis and rat tail collagen (BD Biosciences) 167 
overnight in 0.1% DMSO or drugs dissolved in serum free medium (DMEM/F12 (Life 168 
Technologies)) containing 1% BSA and ITS supplement (Sigma-Aldrich). Cultures 169 
were fixed with 4 % PFA for 1hr at room temperature, and washed with PBS for 4x 170 
30 min. Cultures were blocked with 10% NGS/ 0.2% triton/ PBS for 90 min and 171 
incubated overnight at 4°C with anti–β-Tubulin (1:500; Sigma-Aldrich) in blocking 172 
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solution. Cultures were washed in PBS for 8x30 min washes, incubated overnight at 173 
4°C with goat anti-mouse-IgG-Cy3 (1:2000; Jackson Immunoresearch) in 1% 174 
NGS/PBS, followed by 8x30 min PBS washes. Images were captured using a Nikon 175 
DS5 camera attached to a Nikon SMZ1500 microscope. Image J was used to 176 
quantify total axon outgrowth as described previously (Erskine et al., 2011). Results 177 
are the mean (± s.e.m.) from at least 3 independent experiments for each condition. 178 
Statistical comparisons were made using ANOVA. 179 
 180 
Photography and analysis 181 
Photography was performed using a Nikon SMZ1500 fluorescent stereomicroscope 182 
with a Nikon DS-5 digital camera. Images were prepared and analysed using Adobe 183 
Photoshop and Image J.  184 
 185 
Results 186 
Neurotoxicity of CPS49 in-vitro 187 
To determine if CPS49 is neurotoxic to developing neurons we used an established 188 
mouse retinal explant outgrowth assay (Erskine et al., 2011; Mahony et al., 2013). 189 
E14.5 retinas from C57BL/6J mice were dissected and the explants cultured for 18hr 190 
in a collagen gel with control (DMSO) or CPS49 containing medium, fixed, stained 191 
for neuron-specific β-tubulin, and the extent of axon outgrowth quantified. We found 192 
that compared to the DMSO control CPS49 inhibited neurite outgrowth in a dose-193 
dependent manner (Fig. 1A-E). At 1µg/ml CPS49 had no significant effect on axon 194 
outgrowth (Fig. 1A) but at 5µg/ml and 10µg/ml induced a significant decrease in the 195 
extent of axon outgrowth (Fig. 1B-D). At 40µg/ml CPS49 resulted in complete loss of 196 
outgrowth and, possibly, death of the explants (n=11/12). These findings 197 
demonstrate that CPS49, as with thalidomide, is neurotoxic in vitro.  198 
 199 
Nerve innervation of the developing limb occurs from HH St23/4 and is complete by 200 
HH St31 201 
Next, we examined the extent of limb innervation throughout limb development and 202 
correlated this with the neurotoxic properties of CPS49 using the in vivo chicken 203 
embryo model. First, we established the normal innervation pattern throughout limb 204 
development using immunofluorescence labelling with antibodies specific for 205 
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neurofilaments. We found that innervation of the limb does not begin until after HH 206 
St23/24 (E4), which is approximately 1.5days after the limb bud has formed and 207 
started to grow out from the flank (Fig. 2B). Up to this point the developing limb bud 208 
is aneural (Fig. 2A). Innervation then occurs rapidly and by HH St27/28 (E6.5) 209 
innervation can be seen throughout the proximal and up to medial part of the limb 210 
(Fig. 2C). By HH St31 (E10) axons are present throughout the limb and extending 211 
into the distal handplate (Fig. 2D). 212 
 213 
Neurotoxicity of CPS49 in vivo 214 
To investigate the effect of CPS49 upon limb neuronal innervation, we treated 215 
chicken embryos at a range of developmental timepoints over the upper forelimb. 216 
Following 24hr drug incubation periods, nerve outgrowth was analysed by staining 217 
embryos with antibodies against neurofilaments.  218 
 219 
In embryos treated at HH St17/18 in which limb outgrowth has just begun and the 220 
limb is aneural, application of CPS49 had no significant impact on nerve growth into 221 
the limb (Fig. 3). At 24hrs after drug application, developing nerves had extended a 222 
small distance into the proximal part of the limb in both the control and CPS49 223 
treated embryos (Fig. 3A). However, overall limb area was decreased in CPS49 224 
treated embryos compared to the controls (Fig. 3B, C). These findings demonstrate 225 
that defects in limb growth occur before developing neurites have entered the limb, 226 
and in the absence of obvious defects on initial neurite outgrowth.  227 
We next applied CPS49 to HH St27-28 embryos, when nerves are present 228 
throughout the limb (Fig. 2C), and quantified changes in axon length, distal nerve 229 
area and the limb area 3hr and 24hr after drug application (Fig. 4). Distal axon area 230 
was quantified by measuring total area of the distal end of the radialis profundus 231 
nerve, which is undergoing dynamic growth at this developmental time point (Turney 232 
et al., 2003). At 3hr after application no significant difference was found between 233 
axon length, distal nerve area and limb area between the control and CPS49 treated 234 
limbs (Fig. 4A-A`, B-B`; E, F, G). At 24hr after drug application, CPS49 induced a 235 
small but significant decrease in distal axon area but had no significant effect on 236 
axon length (Fig. 4C-C`, D-D`, E, F). In agreement with our previous findings 237 
demonstrating a time-sensitive window for CPS49-induced limb defects 238 
(Therapontos et al., 2009), total limb area was not altered significantly following 239 
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CPS49 application at this time point, despite some defects in nerve growth (Fig. 4G). 240 
Our findings demonstrate that CPS49 exerts small but significant neurotoxic effects 241 
in vivo but only when applied at a stage of development when nerves are already 242 
present and established within the limb. Normal limb growth can occur despite these 243 
defects in neuronal patterning. 244 
 245 
β-bungarotoxin exposure inhibits limb innervation but does not cause obvious 246 
cartilage pattern changes 247 
We next investigated if loss of nerves within the limb disrupts the final proximo-distal 248 
limb pattern. For these experiments we used β-bungarotoxin, a potent nerve inhibitor 249 
(Chiappinelli et al., 1981; Rugulo et al., 1986). We applied β-bungarotoxin to HH 250 
St18-19 embryos (when the nerves are absent from the limb; Fig. 2A), St23-24 251 
(when nerves have just entered the proximal limb bid; Fig. 2B), and St27-28 embryos 252 
(when nerves are detected up to the medial region; Fig. 2C). Embryos were treated 253 
with β-bungarotoxin then fixed 24hr or 48hr later and nerve growth and limb area 254 
analysed. Treatment for 24hr or 48hr resulted in a significant decrease in nerve 255 
projection within the limb but no change in limb area, when compared to the control 256 
embryos at either 24hr or 48hr (Fig. 5A-F`). Typically, aneural limbs resulted 257 
following 24hr treatment at all timepoints (Fig. 5A, C, E), with some small projections 258 
seen proximally after 48hr treatment at HH St18-19 and HH St23-24 (Fig. 5A, C, E; 259 
n=4/5) which could be due to the neurotoxin effect wearing off and allowing some 260 
reinnervation.  261 
To assess the impact on limb patterning in aneural limbs we next examined limb 262 
cartilage patterning in embryos treated with β-bungarotoxin at HH St15, St17, St20, 263 
St23-24 or St27-28, incubated until E7 or E8, and fixed and stained with alcian blue 264 
to label cartilage. At all timepoints treatment with β-bungarotoxin had no significant 265 
effect on limb patterning which appeared indistinguishable from control limbs. 266 
Moreover, quantification of the total limb length and the lengths of the humerus, 267 
radius, ulna and handplate demonstrated no significant difference between aneural 268 
β-bungarotoxin-treated limbs and control limbs (Fig. 6A, B). These findings 269 
demonstrate that loss of nerves throughout the limb before, during or after limb 270 
outgrowth has occurred has no substantial effects on the final proximo-distal 271 
cartilage pattern or growth of the limb. 272 
 273 
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Discussion 274 
We have shown previously that CPS49 is potently anti-angiogenic, affecting blood 275 
vessel development in chicken embryos within 2hrs of exposure and causing a range 276 
of limb defects in a time sensitive manner (Therapontos et al., 2009). However, 277 
thalidomide is also neurotoxic, but whether this contributes to the limb defects 278 
induced by the drug remains controversial. We have found that CPS49, like 279 
thalidomide is neurotoxic in-vitro. However, using chicken embryos as a model we 280 
have demonstrated that limb outgrowth occurs initially in the absence of nerves and 281 
that application of CPS49 at these early time points (HH St17-18) impairs limb 282 
growth in the absence of any obvious impact on nerve growth and patterning. In 283 
contrast, when applied at HH St27-28 when nerves are present up to the medial part 284 
of the limb, CPS49 causes subtle decreases in neuronal outgrowth, in distal parts of 285 
the limb, but limbs are not reduced in area (Fig. 5F, G), and no apparent cartilage 286 
pattern loss was observed (Fig. 6A). Thus, although CPS49 has neurotoxic actions, 287 
given the late innervation of the limb bud (Fig. 2) and that CPS49 induces defects in 288 
limb growth before innervation has occurred, neurotoxicity cannot explain the 289 
teratogenic effect of CPS49 on the developing limb.  290 
To determine if a loss of nerves contributes to changes in the final proximo-distal 291 
cartilage pattern or additional defects associated with thalidomide embryopathy, β-292 
bungarotoxin was applied at a range of stages. We found no evidence that nerve 293 
inhibition at any of the timepoints we tested causes phocomelic-like defects. Not only 294 
do aneural limbs have normal limb area (Fig. 5), they also have a normal proximo-295 
distal cartilage pattern (Fig. 6). By directly ablating or inhibiting nerves from the limb 296 
over a range of developmental timepoints we have shown that loss of nerves does 297 
not cause the typical CPS49 mediated limb defects (Therapontos et al., 2009).  298 
 299 
Classical studies have investigated the impact of the loss of nerves on the final 300 
cartilage pattern using chick limb tissue transplants, and demonstrated a reduction in 301 
overall skeletal length (Hamburger and Waugh, 1940). More recently, studies have 302 
shown that aneural limbs in chicken embryos have normal cartilage patterns and 303 
also demonstrated that innervation of the limb is a relatively late event (Edom-304 
Vovard et al., 2002; Harsum et al., 2001; Martin and Lewis, 1989; Strecker and 305 
Stephens, 1983; Swanson, 1985; Swanson and Lewis, 1982). Aneural limbs in rats 306 
and tadpoles have reduced cartilage element length and cross sectional area (Dietz, 307 
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1989; Edoff et al., 1997), possibly due to a reduction in osteoblast proliferation and 308 
differentiation, due to a lack of stimulatory neuropeptides normally secreted from the 309 
nerves (Edoff et al., 1997). However, we found that β-bungarotoxin treatment applied 310 
at a range of developmental timepoints before, during and after chicken limb 311 
outgrowth and innervation, eliminated nerves from the limb but did not give 312 
significant reductions in overall or individual skeletal length or induce limb element 313 
patterning changes/loss in chicken embryos. Moreover, we have confirmed previous 314 
findings that innervation of the developing limb is a late event with no nerves in the 315 
limb until at least HH St23/24 (Harsum et al., 2001; Martin and Lewis, 1989; 316 
Swanson and Lewis, 1982). The loss of nerves within our assay may likely give a 317 
small reduction in element lengths had we incubated embryos until a later timepoint. 318 
This is particularly relevant given recent findings detailing the extensive 319 
neuroinnervation of bone and the role of nerves in bone metabolism (Masi, 2012). 320 
Further support for this hypothesis comes from the findings in mice that loss of 321 
Sema3a or TrkA, both involved in axon guidance, results in loss of bone density and 322 
bone length inhibition, but crucially not changes in the pattern of the elements 323 
(Fukada et al., 2013; Tomlinson, et al., 2016). Thus, neurotoxicity, seems to affect 324 
bone length and density, rather than the patterning, number and order of the 325 
cartilage condensations.  326 
 327 
Innervation of the developing chicken limb occurs 1.5days after limb initiation and 328 
outgrowth, and around the time the cartilage condensations for the future long bones 329 
occurs. We have shown that loss of limb innervation does not result in obvious 330 
cartilage pattern loss. However, we cannot exclude that nerve defects could 331 
exacerbate limb defects/damage already caused by thalidomide/CPS49 through 332 
causing misinnervation of remaining bones and, consequently, reduced bone density 333 
or length (Masi, 2012; Fukada et al., 2013; Tomlinson et al., 2016).  334 
 335 
 336 
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Figure Legends 440 
 441 
Figure 1 CPS49 is neurotoxic in vitro  442 
Explants of retinas from E14.5 mice embryos were cultured with DMSO/CPS49 and 443 
after 18hrs, fixed and stained with an anti-β-tubulin antibody and the area of neurite 444 
outgrowth was analysed. (A-D) neurite outgrowth from retinal explants following 0.1 445 
% DMSO or CPS49 treatment. (E) Quantification of neurite outgrowth. Statistical 446 
significance was analysed using one way Anova. Data are mean±SEM. Scale bar, 447 
600µm. White arrowheads indicate areas of neurite outgrowth in control (A) to 448 
compare with neurite outgrowth in treated explants (B-D). NS, not significant 449 
(p>0.05). ****, p<0.001. Numbers on bars of graph indicate number of explants 450 
analysed for each condition. 451 
 452 
Figure 2 Chicken embryo limbs are innervated by neuronal projections after 453 
HH St23/24  454 
 Chicken embryos at HH St 18-19, 23-24, 27-28 and 31 were fixed and stained for a 455 
marker of neurofilaments. (A) HH St18-19 forelimb, (B) HH St23-24 forelimb, (C) HH 456 
St27-28 forelimb. (B) HH St31 forelimb. Scale bar, 300µm. 457 
 458 
Figure 3 CPS49 is not neurotoxic in vivo when applied at HH st17-18 459 
Chicken embryos at HH St17-18 were treated with CPS49 (100 µg/ml), then fixed 460 
after 24hr and stained for a maker of neurofilaments. CPS49 was applied over the 461 
right upper limb. (A) Nerve outgrowth in the forelimb in control or CPS49 treated 462 
embryos. (B, C) Quantification of axon length (B) and limb area (C). Data are 463 
mean±SEM. Statistical significance was analysed using Student`s T-Test. NS,  464 
p>0.05. *, p<0.05.  Scale bar, 100µm. Numbers (n) analysed are indicated in each 465 
panel (A) 466 
 467 
 468 
Figure 4 CPS49 is neurotoxic when applied at HH St27-28 469 
Chicken embryos at HH St27-28 were treated with CPS49 (100 µg/ml), then fixed at 470 
3hr or 24hr and stained for a maker of neurofilaments. CPS49 was applied over the 471 
right forelimb. (A-D`) Nerve outgrowth in the forelimb in control or CPS49 treated 472 
embryos. (E-G) Quantification of proximo-distal axon protrusion (distance from body 473 
wall to most distal axonal projection; (E), area of the distal end of the radialis 474 
profundus nerve (F) and total limb area (G) in control and CPS49 treated limbs. 475 
Statistical significance was analysed using Student`s T-Test. Data are mean±SEM. 476 
NS, not significant, (p>0.05). *, p<0.05.  Scale bar, 300µm. Numbers on graph bars 477 
indicate N numbers analysed. 478 
 479 
Figure 5  Neural ablation does not change limb size 480 
Chicken embryos at HH St 18-19, 23-24, or 27-28 were treated with β-bungarotoxin, 481 
and incubated for 24hr or 48hr. Innervation was visualised using 3A10 anti-482 
neurofilament anti-body staining. The limb area and length of the most distal 483 
neuronal projection was measured. Embryos treated with β-bungarotoxin at HH 484 
St18-19 (A-E`), HH St23-24 embryos (F-J`) and HH St27-28 embryos (K-O`) showed 485 
reductions in nerve length at 24hr, and following 48hr incubation, with no change in 486 
limb area, when compared to the control embryos. In contrast to treatments at HH 487 
St18-19 and HH St23-24 where some recovery of neuronal projections in proximal 488 
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parts of the limb were found following 48hr incubation, treatment at HH St27 were 489 
aneural with no recovery of neuronal projections observed. Statistical significance 490 
was analysed using Student`s T-Test. Data are mean±SEM. Numbers (n) analysed 491 
are indicated in each panel (A, C, E). in each panel, refers to N number. NS= 492 
p>0.05, *= p<0.01, ****= p<0.001.  Scale bar, 300µm.  493 
 494 
  495 
Figure 6 Aneural limbs have normal cartilage pattern 496 
Control or β-bungarotoxin treated chicken embryos incubated until day 7 (HH St30) 497 
or day 8 (HH St31). Embryos were then cartilage stained and imaged to examine 498 
proximal to distal elements. (A) Control and β-bungarotoxin treated embryos treated 499 
at a variety of timepoints gave normal cartilage pattern. (B) Measurement of proximal 500 
to distal skeletal elements normalized to control limbs showed no decrease in 501 
aneural limb length relative to the average measurements from DMSO or 502 
contralateral control limbs. Data are mean±SD. Numbers (n) analysed are indicated 503 
in each panel (A). Scale bar, 300µm. 504 
 505 
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